TruSpine Technologies #TSP – Result of GM & Change of Name August 22, 2025 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that at its GM held earlier today all resolutions were duly passed. Change of Name Once the change of the Company’s name to TSP Advanced Technologies plc takes effect, the Company’s ticker for AQSE will remain as TSP. The Company’s new website address, containing the information required to be published pursuant to Rule 4.14 of the AQSE Growth Market Access…

TruSpine #TSP – Bitcoin Treasury Policy June 25, 2025 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it actively pursuing the implementation of a Bitcoin Treasury Policy. The Company will continue to focus on its core business, whilst growing a bitcoin treasury to facilitate the funding of such business over the medium-term. The Company’s Bitcoin Treasury Policy will align with the Directors’ views that bitcoin provides a means to preserve value over time and serve as…

#TSP TruSpine Plc – Update on AQSE Fine May 20, 2025 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that, following a Warning Notice issued by Aquis Stock Exchange (“AQSE”) on 1 May 2025, AQSE Regulation has decided to enforce £15,000 of the £165,000 suspended element of the £215,000 fine originally imposed on the Company under the Disciplinary Decision Notice published on 16 August 2023. The fine will be settled from the Company’s existing cash resources. The remaining…

TruSpine #TSP – Investor Webinar April 7, 2025 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, is pleased to announce a live Webinar hosted by Geoff Miller, CEO of the Company, via the Company’s recently updated Investor website on Friday, 11 April 2025, at 10:00 AM BST. This session is open to all existing and prospective shareholders. Questions can be submitted in advance via the webinar page until Wednesday, 9 April 2025 at 10:00 AM BST, or…

TruSpine #TSP – Notice of 2024 AGM March 17, 2025 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that notice of the Company’s 2024 annual general meeting (“2024 AGM”) has been sent to shareholders. The 2024 AGM will be held at Regus, Crawley, Gatwick Airport Manor Royal, Churchill Court 3, Crawley, RH10 9LU on 10 April 2025 at 11:00 am. A copy of the notice of the 2024 AGM, along with the form of proxy, will be shortly…

TruSpine #TSP – Interim Results – for the six months ended 30 September 2024 December 23, 2024 – Posted in: TruSpine Plc (TSP)

Interim Results – for the six months ended 30 September 2024 CHAIRMAN’S REPORT During the period under review and the period to date the Company is pleased to have made progress on three fronts namely:- the FDA submission is progressing and the Company is hoping for more substantive news in 2025. Following a turbulent year, the Company looks forward to a more constructive future, as it works towards commercialisation of its IP. Financing: the Company…

Alan Green covers Rome Resources, Fulcrum Metals #FMET & Truspine Technologies #TSP on this week’s Stockbox Research Talks June 9, 2024 – Posted in: Blog, TruSpine Plc (TSP)

Alan Green covers Rome Resources, Fulcrum Metals #FMET & Truspine Technologies #TSP on this week’s Stockbox Research Talks

#TSP TruSpine Technologies PLC – Major Shareholding May 29, 2024 – Posted in: TruSpine Plc (TSP)

TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: TruSpine Technologies PLC 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) Non-UK issuer 2. Reason for…

#TSP TruSpine Technologies – Director Dealing March 18, 2024 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it received notification on 15 March 2024 that Geoff Miller, Chairman of the Company, made the following purchase of ordinary shares in the capital of the Company on 15 March 2024. Further details are set out in the Notification of Dealing Form below. Director Purchase price (Aggregated) Ordinary shares purchased Resultant interest in ordinary shares Resultant percentage of issued…

#TSP Truspine Technologies PLC – Loan, Related Party Transaction and FDA Update January 5, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it has entered into a £30,000 loan agreement with Annabel Schild (the “Loan Agreement”), a former Non-Executive Director of the Company within 12 months of the Loan Agreement being entered into and therefore is considered a related party pursuant to the AQSE Growth Market Access Rulebook. The Company also provides an update on its U.S. Food and Drug Administration…